ZEISS ends successful fiscal year 2012/13
In fiscal year 2012/13 different developments were observed in the market segments relevant to ZEISS. Overall, the market situation was tense: while slight growth was reported in the market for medical technology, the markets for microscopy, industrial metrology and eyeglass lenses remained stable. Demand in the market for lithography systems continued to decline in the first half of the fiscal year compared to the previous year, but picked up again in the second half. "In fiscal year 2012/13 we reached and partly exceeded our targets. ZEISS put in a good performance despite the challenging business environment and the weakness of the economy at the beginning of the year," said Dr. Michael Kaschke, President and CEO of Carl Zeiss AG. "We made no compromises in our multi-year investment program – the biggest ever in the company's history – but continued to implement it consistently and systematically.“
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.